Moderna Inc (NASDAQ: MRNA) shares, which closed in record territory Friday, are adding to their gains following the release of primary analysis of the Phase 3 study that...
source https://www.benzinga.com/general/biotech/20/11/18573749/modernas-stock-hits-new-highs-after-covid-19-vaccine-analysis-confirms-94-efficacy